Very true.
But remember PTX100 expansion trial is positioning for a fast track approval. So a phase 2b trial leading to FDA approval. Well achievable for a company like PTX.
So potential future revenue from drug to market, OmniCar and cool cell tech.
Think of what market cap the above would command?
Our market cap now doesnt fully cover the pipeline as it is, so we have lots of room for the share to still move. The support seen at 18 to 18.5c is bullish.
updated chart, page-2445
-
- There are more pages in this discussion • 834 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
